KATP blocker 1908: AVE said it discontinued development of KATP blocker 1908, which was in Phase IIa testing. The company also discontinued development of metab

Aventis S.A. (AVE), Strasbourg, France
Product: KATP

Read the full 75 word article

How to gain access

Continue reading with a
two-week free trial.